Ottimo Pharma
Private · United Kingdom
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
1 active
1 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
PD-1/VEGFR2 bifunctional antibody |
Phase 1/2 | Dec 2028Phase 1/2 trial completes | |||
| How it works | A cancer drug that hits two targets at once | ||||
| Next date | Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: Ottimo Pharma is private
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev